On August 20, 2009
“CASSPER” Was GSK’s Friendly Ghostwriting Program on Paxil
GlaxoSmithKline had a ghostwriting program named CASSPER, the AP reports. Five journals — including the American Journal of Psychiatry and the Journal of the American Academy of Child and Adolescent Psychiatry — published papers written under the CASSPER program between 2000 and 2002.
0 Comments